Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Annals of Surgical Oncology|January 4, 2021
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)Katherin Zambrano-Vera, Armando Sardi, Felipe Lopez-Ramirez, et al.Annals of Surgical Oncology|December 28, 2023
Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the AppendixFelipe Lopez-Ramirez, Armando Sardi, Mary Caitlin King, et al.Pleura and Peritoneum|April 1, 2024
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.Cancers|August 14, 2025
Ensuring Reproducibility and Deploying Models with the Image2Radiomics Framework: An Evaluation of Image Processing on PanNET Model PerformanceFlorent Tixier, Felipe Lopez-Ramirez, Emir A Syailendra, et al.World Journal of Surgical Oncology|August 26, 2025
Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgeryLuis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.International Journal of Surgical Oncology|December 31, 2020
Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)Carlos A Munoz-Zuluaga, Armando Sardi, Michelle Sittig, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 14, 2025
Controlling perfusion temperature relates to better outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyFelipe Lopez-Ramirez, Kseniia Uzhegova, Mary Caitlin King, et al.Annals of Surgical Oncology|July 26, 2024
Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors' Perspective Through In-Depth InterviewsLuis Felipe Falla-Zuniga, Mary Caitlin King, Kathleen Pawlikowski, et al.Radiology Case Reports|September 16, 2024
Diminishing calcifications as a potential predictor of pancreatic ductal adenocarcinoma arising in association with IPMN in patients with chronic pancreatitisMohammad Yasrab, Ryan C Rizk, Felipe Lopez-Ramirez, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 17, 2023
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcomaFelipe Lopez-Ramirez, Armando Sardi, Kimberley Studeman, et al.Pageof 5